BioSpace

Centinel Spine® Receives FDA Approval for Two-Level Use of prodisc® C Nova, Further Expanding the Match-The-Disc™ Cervical Portfolio

With this approval, pro disc® C Nova joins pro disc C Vivo and pro disc C SK as three distinct pro disc cervical TDR devices ...
Health and Me on MSN

FDA approves new treatment option for bladder cancer unresponsive to standard immunotherapy

The US Food and Drug Administration recently approved an alternative treatment option for patients with BCG-unresponsive high ...
BioSpace

Florida Cancer Specialists & Research Institute Contributes to Two Significant FDA Approvals Advancing Breast and Pancreatic Cancer Care

Florida Cancer Specialists & Research Institute, LLC (FCS) is celebrating its pivotal role in the development of two recently ...
The Brighterside of News on MSN

FDA approves once-daily Parkinson’s pill (Juvmo) built on decades of work by husband-and-wife team

Once-daily tavapadon offers a new Parkinson’s treatment option, with symptom benefits supported by trials and important ...
Healio

Following FDA approval, oral brepocitinib ‘on the forefront’ in dermatomyositis therapy

The FDA approval of brepocitinib as the first oral drug for dermatomyositis has placed it “on the forefront” of treatment for ...

FDA’s New Leadership Aims to Overhaul Rare Disease Approvals

The US Food and Drug Administration is kicking off a top-to-bottom review of how it approaches rare disease drug development ...
Medscape

FDA Expands Anktiva Approval in Bladder Cancer

The agency used a 'new approach' to broaden the drug's indication to include patients with BCG-unresponsive non-muscle invasive bladder cancer whose tumors are papillary-only.
Mens Fitness on MSN

New FDA Approval Aims to Help Patients Avoid Bladder Removal Surgery

The decision gives certain patients whose cancer has resisted BCG therapy another treatment option aimed at preserving the bladder. Here’s who qualifies and what the evidence shows.

IBRX Stock Eyes Weekly Slump Despite Anktiva FDA Win — Retail Stays Cautious Ahead Of Founder’s Trial Talk

Shares of ImmunityBio (IBRX) are on track for a weekly loss even after securing a broader U.S. approval for its flagship ...
The American Journal of Managed Care

FDA Approves First Treatment for BCG-Unresponsive Bladder Cancer

Nogapendekin alfa inbakicept-pmln (Anktiva; ImmunityBio Inc) given with Bacillus Calmette-Guérin (BCG) is now the first ...

The FDA recently approved a COVID prevention medicine — here’s how it works

The recently-approved medication can help keep you from getting COVID if you’re directly exposed to the illness.
Healio

FDA expands Anktiva immunotherapy approval for BCG-unresponsive bladder cancer

The FDA expanded approval of Anktiva for bladder cancer. The agent is the first approved treatment for BCG-unresponsive, high ...